J R Hampton

Summary

Affiliation: University of Nottingham
Country: UK

Publications

  1. ncbi Different causes of heart failure need different treatment strategies
    J R Hampton
    Cardiovascular Medicine, University Hospital, Nottingham, UK
    J Cardiovasc Pharmacol 33:S37-41. 1999
  2. ncbi Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy
    J R Hampton
    Cardiovascular Medicine, University Hospital, Nottingham, UK
    Eur J Heart Fail 1:89-93. 1999
  3. ncbi Evidence-based medicine, opinion-based medicine, and real-world medicine
    John R Hampton
    University Hospital, Nottingham, United Kingdom
    Perspect Biol Med 45:549-68. 2002
  4. ncbi Size isn't everything
    J R Hampton
    Cardiology Department, University Hospital, Nottingham NG7 2UH, UK
    Stat Med 21:2807-14. 2002
  5. ncbi Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators
    J R Hampton
    Queen s Medical Centre, University Hospital, Nottingham, UK
    Lancet 349:971-7. 1997
  6. ncbi Circadian variation in witnessed out of hospital cardiac arrest
    L H Soo
    Department of Cardiovascular Medicine, University Hospital, Queens Medical Centre, University Hospital, Nottingham NG7 2UH, UK
    Heart 84:370-6. 2000
  7. ncbi Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial
    A R Houghton
    Department of Cardiovascular Medicine, University Hospital, Queen s Medical Centre, Nottingham, United Kingdom
    Am Heart J 140:e25. 2000
  8. ncbi Geographical distribution of cardiac arrest in Nottinghamshire
    L Soo
    Department of Cardiovascular Medicine, Queens Medical Centre, University Hospital, Nottingham, UK
    Resuscitation 48:137-47. 2001
  9. ncbi Pathological features of witnessed out-of-hospital cardiac arrest presenting with ventricular fibrillation
    L H Soo
    Department of Cardiovascular Medicine, Queens Medical Centre, University Hospital, NG7 2UH, Nottingham, UK
    Resuscitation 51:257-64. 2001
  10. ncbi Treatment bias and clinical judgement
    John R Hampton
    Age Ageing 31:3-4. 2002

Detail Information

Publications11

  1. ncbi Different causes of heart failure need different treatment strategies
    J R Hampton
    Cardiovascular Medicine, University Hospital, Nottingham, UK
    J Cardiovasc Pharmacol 33:S37-41. 1999
    ..These suggest that patients with different causes of heart failure respond to treatment in different ways...
  2. ncbi Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy
    J R Hampton
    Cardiovascular Medicine, University Hospital, Nottingham, UK
    Eur J Heart Fail 1:89-93. 1999
    ..The inclusion and exclusion criteria used for PRIME II, and the definitions of mode of death, were effective. The PRIME II protocol can be used as a model for future heart failure studies...
  3. ncbi Evidence-based medicine, opinion-based medicine, and real-world medicine
    John R Hampton
    University Hospital, Nottingham, United Kingdom
    Perspect Biol Med 45:549-68. 2002
    ..For each patient a judgment has to be made by the clinician of the likely balance of risks and benefits of any therapy. Good practice still requires clinical freedom for doctors...
  4. ncbi Size isn't everything
    J R Hampton
    Cardiology Department, University Hospital, Nottingham NG7 2UH, UK
    Stat Med 21:2807-14. 2002
    ..Clinical trials often do not reflect 'real world' practice, and the clinical relevance of a trial is more important than its size...
  5. ncbi Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators
    J R Hampton
    Queen s Medical Centre, University Hospital, Nottingham, UK
    Lancet 349:971-7. 1997
    ..We assessed the effect of ibopamine on survival in patients with advanced heart failure in a multicentre, randomised placebo-controlled study...
  6. ncbi Circadian variation in witnessed out of hospital cardiac arrest
    L H Soo
    Department of Cardiovascular Medicine, University Hospital, Queens Medical Centre, University Hospital, Nottingham NG7 2UH, UK
    Heart 84:370-6. 2000
    ....
  7. ncbi Combined treatment with losartan and an ACE inhibitor in mild to moderate heart failure: results of a double-blind, randomized, placebo-controlled trial
    A R Houghton
    Department of Cardiovascular Medicine, University Hospital, Queen s Medical Centre, Nottingham, United Kingdom
    Am Heart J 140:e25. 2000
    ..Although the beneficial effects of angiotensin-converting enzyme (ACE) inhibitors in patients with heart failure are well recognized, there are theoretical advantages in combining ACE inhibition with angiotensin (AT)1 receptor antagonism...
  8. ncbi Geographical distribution of cardiac arrest in Nottinghamshire
    L Soo
    Department of Cardiovascular Medicine, Queens Medical Centre, University Hospital, Nottingham, UK
    Resuscitation 48:137-47. 2001
    ....
  9. ncbi Pathological features of witnessed out-of-hospital cardiac arrest presenting with ventricular fibrillation
    L H Soo
    Department of Cardiovascular Medicine, Queens Medical Centre, University Hospital, NG7 2UH, Nottingham, UK
    Resuscitation 51:257-64. 2001
    ....
  10. ncbi Treatment bias and clinical judgement
    John R Hampton
    Age Ageing 31:3-4. 2002
  11. ncbi Guidelines--for the obedience of fools and the guidance of wise men?
    John R Hampton
    University of Nottingham
    Clin Med 3:279-84. 2003
    ..A guideline will depend on the opinions of those who wrote it, and the wise man will use his judgement and give due weight to his own opinions and expertise...